The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1136
ISSUE1136
August 5, 2002
Olmesartan (Benicar) for hypertension
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Olmesartan (Benicar) for hypertension
August 5, 2002 (Issue: 1136)
Olmesartan medoxomil (Benicar - Sankyo), a substituted imidazole, is the seventh oral angiotensin II receptor blocker (ARB) approved by the FDA for treatment of hypertension.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.